4D Molecular Therapeutics launches $250M stock offering By Investing.com
© Reuters. EMERYVILLE, Calif. - 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), a clinical-stage genetic medicines company, announced today that it has ...
© Reuters. EMERYVILLE, Calif. - 4D Molecular Therapeutics, Inc. (NASDAQ:FDMT), a clinical-stage genetic medicines company, announced today that it has ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.